Nebraska Reportable Disease Surveillance

GUIDE TO REPORTABLE DISEASES, POISONINGS, ORGANISMS, AND EVENTS

Malaria (Plasmodium species) Acinetobacter spp., ‡ Measles (Rubeola) Melioidosis [Burkholderia (Pseudomonas) pseudomallei]* ‡ Acquired Immunodeficiency Syndrome (AIDS) Meningitis (Haemophilus influenzae^ or Neisseria meningitidis^) Meningitis, viral, bacterial, and fungal Adenovirus infection (conjunctivitis, respiratory) Meningococcal disease, invasive (Neisseria meningitidis^) Methemoglobinemia / nitrate poisoning (methemoglobin greater than 5% of Amebae-associated infection (Acanthamoeba spp., Entamoeba histolytica, and total hemoglobin) Naegleria fowleri Monkeypox virus infection* Mumps Anthrax (Bacillus anthracis^)* ‡ Mycobacteria spp. (M. tuberculosis complex organisms^ and all “atypical” species indicative of tuberculosis infection or disease) ‡ Arboviral infections (including but not limited West Nile virus, St. Louis Necrotizing fasciitis encephalitis virus, Western Equine Encephalitis virus, and Dengue virus)* Norovirus infection (laboratories only) Pertussis [whooping cough] (Bordetella pertussis^) ‡ Babesiosis (Babesia species) Plague (Yersinia pestis^)* ‡ Poisoning or illness due to exposure to agricultural chemicals, industrial Botulism (Clostridium botulinum^)* chemicals, mercury, or radiologic exposures Poliomyelitis, paralytic Brucellosis (Brucella abortus^, B. melitensis^, and B. suis^*‡ Q fever (Coxiella burnetii^)* ‡ Rabies (human and animal cases and suspects) Campylobacteriosis (Campylobacter^ species) ‡ Respiratory syncytial virus infection (laboratories only) Retrovirus infections (other than HIV) Carbon monoxide poisoning (use breakpoint for non-smokers) Rheumatic fever, acute (cases meeting the Jones criteria only) Ricin poisoning* Chancroid (Haemophilus ducreyi ) ‡± Rift Valley fever* Rocky Mountain Spotted Fever (Rickettsia rickettsii^)* Chlamydia trachomatis infections ‡± Rotavirus infection ([all positive and negative tests] applies only to laboratories performing electronic lab reporting as described in 173 NAC 1-005.02C Cholera (Vibrio cholerae^) ‡ Rubella and congenital rubella syndrome Salmonellosis, including typhoid fever (Salmonella serogroup^) ‡ Clostridium difficile Severe Acute Respiratory Syndrome [SARS] (SARS-associated coronavirus) Shiga toxin-positive gastroenteritis (enterohemorrhagic E. coli and other shiga Clusters, Outbreaks, or Unusual Events, Including Possible Bioterroristic toxin-producing bacteria^) Attacks* Shigellosis (Shigella species^) ‡ Smallpox* Coccidiodomycosis (Coccidioides immitis/posodasiI^)* Staphylococcal enterotoxin B intoxication* ‡ Staphylococcus aureus (applies only to laboratories performing electronic lab Creutzfeldt-Jakob Disease (subacute spongiform encephalopathy reporting as specified in 1-005.02C) Staphylococcus aureus, vancomycin-intermediate/resistant (MIC > 4 Cryptosporidiosis (Cryptosporidium parvum) µg/mL) ‡ Streptococcal disease (all invasive disease caused by Groups A and B Cyclosporiasis (Cyclospora cayetanensis) streptococci) ‡ Streptococcus pneumoniae, all isolates ‡ Diphtheria (Corynebacterium diphtheriae) ‡ Syphilis (Treponema pallidum) RPR and FTA reactive ± Syphilis, congenital Eastern equine encephalitis (EEE virus^)* Tetanus (Clostridium tetani) ‡ Tick-borne encephalitis, virus complexes (Central European Tick-borne Ehrlichiosis, human granulocytic (Ehrlichia phagocytophila) encephalitis virus, Far Eastern Tick-borne encephalitis virus, Kyasanur Forest disease virus, Omsk Hemorrhagic Fever virus, Russian Spring and Ehrlichiosis, human monocytic (Ehrlichia chaffeenis) ‡ Summer encephalitis virus)* Toxic shock syndrome Encephalitis (caused by viral agents) Toxoplasmosis, acute (Toxoplasma gondii) Transmissible spongiform encephalopathies Enterococcus spp. ‡ Trichinosis (Trichinella spiralis) Tuberculosis (see Mycobacteria) Escherichia coli gastroenteritis (E. coli O157-H7^ and other Shigatoxin-positive Tularemia (Francisella tularensis^)*‡ E. coli from gastrointestinal infection^) Typhus Fever, louse-borne (Rickettsia prowazekii^)* and flea-borne / endemic murine (Rickettsia typhi) Food poisoning, outbreak-associated Varicella death (all ages) Varicella primary infections (chicken pox) Giardiasis (Giardia lamblia) Venezuelan equine encephalitis* Viral hemorrhagic fever (including but not limited to Ebola virus, Marburg Glanders [Burkholderia (Pseudomonas) mallei^]* ‡ virus, and Lassa fever virus)* Yellow Fever Gonorrhea (Neisseria gonorrhoeae): venereal infection and ophthalmia Yersiniosis (Yersinia species not Y. pestis) ‡ neonatorum ‡±

Haemophilus influenzae infection (invasive disease only)^ ‡

Hansen’s Disease (Leprosy [Mycobacterium leprae]) ‡

Hantavirus pulmonary syndrome (Sin Nombre virus)

Hemolytic uremic syndrome (post-diarrheal illness)

Hepatitis A (IgM antibody-positive or clinically diagnosed during an outbreak)

Hepatitis B infection (positive surface antigen tests and all IgM core antibody tests, both positive and negative) ±

Hepatitis C infection (all positive screening tests to include signal-to-cutoff ratio [S:CO] are reportable; all confirmatory tests are reportable regardless of result)

Hepatitis D and E infection

Herpes simplex, primary genital infection ±

Histoplasmosis (Histoplasma capsulatum)

Human immunodeficiency virus infection

Influenza (Antigen or PCR positive or culture confirmed)

Influenza deaths, pediatric (< 18 years of age)

Influenza due to novel or pandemic strains (includes highly pathogenic avian influenza virus^)*

Influenza, all tests (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Influenza, rapid tests summary report only (laboratories only)

Kawasaki disease (mucocutaneous lymph node syndrome)

Klebsiella sp., ‡

Lead poisoning (all analytical values for blood lead analysis)

Legionellosis (Legionella species) ‡

Leptospirosis (Leptospira interrogans)

Listeriosis (Listeria monocytogenes^) ‡

Lyme disease (Borrelia burgdorferi)

Lymphocytic choriomeningitis virus infection

Lymphogranuloma venereum (LGV [Chlamydia trachomatis]) ±

Bold Type: Report immediately | Plain Type: Report within seven days

* Potential agents of bioterrorism (designated as select agents by CDC)

^ Laboratories must submit the isolate and/or specimen to the Nebraska Public Health Laboratory as specified in 173 NAC 1-007.03. ‡ Laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C must report any antibiotic susceptibility test results

± STD in accordance with Neb. Rev. Stat. § 71-502.01.

Nebraska Department of Health and Human Services, Office of Epidemiology, PO Box 95026, NE 68509, Phone 402-471-2937 Fax 402-471-3601.

Reportable Diseases – Nebraska 2014 Confirmed and Probable Cases by Condition and Year, Nebraska CONDITION 2014 2013 YTD 2013 Total 2012 Total YTD Amebiasis 1 1 15 7 Anaplasma phagocytophilum 0 0 2 2 Animal Exposure (bite or nonbite) 113 70 722 452 Aseptic meningitis 11 8 108 133 Babesiosis 0 0 1 1 Bacterial meningitis, other 3 1 7 8 Botulism (infant) 0 1 1 0 Brucellosis 0 1 3 0 Campylobacteriosis 69 81 482 467 Chlamydia trachomatis infection 2 0 0 0 Coccidioidomycosis 1 0 1 1 Cryptosporidiosis 17 21 155 163 Cyclosporiasis 0 0 91 0 Dengue Fever 0 0 1 3 Ehrlichiosis, Human, other & unspecified 0 0 1 0 Ehrlichiosis, chaffeensis 0 0 6 0 Encephalitis primary, other 3 0 1 1 Giardiasis 34 47 177 200 Group A Streptococcus, invasive 22 10 33 29 Group B Streptococcus, invasive 34 17 92 73 Haemophilus influenzae, invasive 6 9 31 31 Hansen disease (Leprosy) 0 0 1 0 Hemolytic uremic syndrome, post-diarrheal 0 0 3 1 Hepatitis A, acute 2 5 15 17 Hepatitis B virus infection, chronic 62 72 238 197 Hepatitis B, acute 2 5 16 7 CONDITION 2014 2013 YTD 2013 Total 2012 Total YTD Hepatitis C Virus Infection, chronic or resolved 285 360 1,093 942 Hepatitis C, acute 1 1 2 2 Hepatitis Delta co- or super-infection, acute 1 0 1 0 Histoplasmosis 3 8 20 72 Influenza Outbreak 0 1 1 0 Influenza, human isolates 20 503 532 587 Kawasaki disease 2 0 4 9 Lead poisoning (Adult) 79 0 6 0 Lead poisoning (Child) 5 1 30 3 Legionellosis 1 11 22 13 Listeriosis 0 0 2 4 Lyme disease 3 0 10 12 Malaria 0 1 7 4 Mumps 0 0 0 1 Mycobacterium Avium 9 7 14 24 Mycobacterium, non-TB (organism) 13 14 34 35 Necrotizing fasciitis 0 0 1 0 Neisseria meningitidis, invasive (Mening. disease) 0 3 5 3 Noroviruses 106 58 113 68 Pertussis 64 45 244 242 Psittacosis (Ornithosis) 0 0 1 0 Q fever, Acute 0 0 4 3 Q fever, Chronic 0 1 5 3 RSV 80 239 250 86 Rabies, animal 4 10 34 60 Rheumatic fever (Acute) 0 1 1 1 Rotavirus 0 0 0 30 S. aureus, coag+, meth- or oxi- resistant (MRSA) 0 2 4 2 Salmonella 0 0 0 2 Salmonellosis 29 55 309 358 Shiga toxin-producing Escherichia coli (STEC) 9 8 81 109 Shigellosis 11 15 71 279 Spotted Fever Rickettsiosis 0 0 17 8 Strep pneumoniae, invasive 0 1 3 1 Strep, other, invasive, beta-hem (non-A nonB) 2 1 3 3 Streptococcal toxic-shock syndrome 0 0 0 1 Streptococcus pneumoniae, invasive disease 53 63 169 147 (IPD) Trichinosis (Trichinellosis) 0 0 1 1 Tuberculosis 6 4 23 23 Tuberculosis LTBI - Latent Infection 0 0 6 0 Tularemia 0 1 17 6 Vancomycin-Resistant Enterococcus 1 0 1 0 Varicella (Chickenpox) 4 6 25 40 Vibrio parahaemolyticus (non-Cholera) 0 0 3 0 Vibrio sp., non-toxigenic, other/unspecified 0 0 0 1 Vibriosis (non-cholera Vibrio species infections) 0 0 0 1 West Nile Fever 2 4 179 146 West Nile, Encephalitis/meningitis 0 2 55 43 Yersiniosis (not Plague) 1 2 7 3